Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016

Harishankar Sahu; Naresh Mali; Vrinda Mathur

doi:doi:10.11648/j.ijafrm.20160101.16

| Peer-Reviewed

Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016

Harishankar Sahu, Naresh Mali, Vrinda Mathur

Published in International Journal of Accounting, Finance and Risk Management (Volume 1, Issue 1)

Received: 10 September 2016 Accepted: 19 November 2016 Published: 20 December 2016

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The Indian Pharma industry is on a robust growth path and is likely to be in the top 10 global markets in value term by 2020. Indian pharmaceutical sector accounts for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and it is expecting to expand at a Compound Annual Growth Rate of 15.92 per cent to US$ 55 billion by 2020. By 2016-17, India is expecting to be the third-largest global generic Active Pharmaceutical Ingredient merchant market. This study seeks to describe the status of Indian pharmaceutical companies, their position, ranking, financial status and forecasting of future opportunities based on the financial predictors i.e. Net sales, total share capital net profit, total assets, total income. The ranking of the top 10 companies’ changes drastically when they ranked based on total share capital and net profit. The financial stability of the companies can be described as they contribute more in market capitalization but are lagging behind in the ranking based on net profits and total share capital.

Published in	International Journal of Accounting, Finance and Risk Management (Volume 1, Issue 1)
DOI	10.11648/j.ijafrm.20160101.16
Page(s)	39-45
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2016. Published by Science Publishing Group

Keywords

Financial Predictors, Ranking, Indian Pharmaceutical Company, Market Capital

References

[1]	Indian Pharmaceutical Industry. (2012). Retrieved July 5, 2016, from Business Maps of India.com: http://business.mapsofindia.com/pharmaceutical/.
[2]	Pharma Industry. (2014). Retrieved July 3, 2016, from Shine: http://info.shine.com/industry/pharma/2.html.
[3]	Pharmaceutical Companies in India. (2015). Retrieved July 5, 2016, from Business Maps of India.com: http://business.mapsofindia.com/india-company/pharmaceutical.html.
[4]	TOP 10 PHARMA COMPANIES IN INDIA 2016. (2016, Jan 16). Retrieved July 4, 2016, from Listz: http://listz.in/top-10-pharma-companies-in-india.html#ixzz4DF67kTWw.
[5]	Accounting Tools. (n.d.). Retrieved July 10, 2016, from Accounting tools: http://www.accountingtools.com/.
[6]	Dr. Aman Trehan, M. A. (n.d.). Indian Pharma Industry: Trends, Predictions and Challenges. Retrieved July 3, 2016, from Asia-Pacific Biotech News: http://www.asiabiotech.com/18/1801/18010027x.html.
[7]	Investopedia. (n.d.). Retrieved July 10, 2016, from Investopedia: http://www.investopedia.com/terms/n/netincome.asp?ad=dirN&qo=investopediaSiteSearch&qsrc=0&o=40186.
[8]	Investor words. (n.d.). Retrieved July 10, 2016, from Investor words Web Site: http://www.investorwords.com/3259/net_profit.html.
[9]	Sharma, H. (2013, Jan 2). Indian pharmaceutical industry growth intact amid current headwinds faced by industry. Retrieved July 4, 2016, from Express Pharma: http://archivepharma.financialexpress.com/sections/market-section/1593-indian-pharmaceutical-industry-growth-intact-amid-current-headwinds-faced-by-industry.
[10]	V, N. (2015). Indian Pharma betting big on Uncle Sam. Retrieved July 6, 2016, from The Hindu Business Line: http://www.thehindubusinessline.com/portfolio/indian-pharma-betting-big-on-uncle-sam/article7723173.ece.

Cite This Article

Plain Text BibTeX RIS

APA Style

Harishankar Sahu, Naresh Mali, Vrinda Mathur. (2016). Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016. International Journal of Accounting, Finance and Risk Management, 1(1), 39-45. https://doi.org/10.11648/j.ijafrm.20160101.16

Copy | Download

ACS Style

Harishankar Sahu; Naresh Mali; Vrinda Mathur. Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016. Int. J. Account. Finance Risk Manag. 2016, 1(1), 39-45. doi: 10.11648/j.ijafrm.20160101.16

Copy | Download

AMA Style

Harishankar Sahu, Naresh Mali, Vrinda Mathur. Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016. Int J Account Finance Risk Manag. 2016;1(1):39-45. doi: 10.11648/j.ijafrm.20160101.16

Copy | Download

@article{10.11648/j.ijafrm.20160101.16,
  author = {Harishankar Sahu and Naresh Mali and Vrinda Mathur},
  title = {Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016},
  journal = {International Journal of Accounting, Finance and Risk Management},
  volume = {1},
  number = {1},
  pages = {39-45},
  doi = {10.11648/j.ijafrm.20160101.16},
  url = {https://doi.org/10.11648/j.ijafrm.20160101.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijafrm.20160101.16},
  abstract = {The Indian Pharma industry is on a robust growth path and is likely to be in the top 10 global markets in value term by 2020. Indian pharmaceutical sector accounts for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and it is expecting to expand at a Compound Annual Growth Rate of 15.92 per cent to US$ 55 billion by 2020. By 2016-17, India is expecting to be the third-largest global generic Active Pharmaceutical Ingredient merchant market. This study seeks to describe the status of Indian pharmaceutical companies, their position, ranking, financial status and forecasting of future opportunities based on the financial predictors i.e. Net sales, total share capital net profit, total assets, total income. The ranking of the top 10 companies’ changes drastically when they ranked based on total share capital and net profit. The financial stability of the companies can be described as they contribute more in market capitalization but are lagging behind in the ranking based on net profits and total share capital.},
 year = {2016}
}

Copy | Download

TY  - JOUR
T1  - Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016
AU  - Harishankar Sahu
AU  - Naresh Mali
AU  - Vrinda Mathur
Y1  - 2016/12/20
PY  - 2016
N1  - https://doi.org/10.11648/j.ijafrm.20160101.16
DO  - 10.11648/j.ijafrm.20160101.16
T2  - International Journal of Accounting, Finance and Risk Management
JF  - International Journal of Accounting, Finance and Risk Management
JO  - International Journal of Accounting, Finance and Risk Management
SP  - 39
EP  - 45
PB  - Science Publishing Group
SN  - 2578-9376
UR  - https://doi.org/10.11648/j.ijafrm.20160101.16
AB  - The Indian Pharma industry is on a robust growth path and is likely to be in the top 10 global markets in value term by 2020. Indian pharmaceutical sector accounts for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and it is expecting to expand at a Compound Annual Growth Rate of 15.92 per cent to US$ 55 billion by 2020. By 2016-17, India is expecting to be the third-largest global generic Active Pharmaceutical Ingredient merchant market. This study seeks to describe the status of Indian pharmaceutical companies, their position, ranking, financial status and forecasting of future opportunities based on the financial predictors i.e. Net sales, total share capital net profit, total assets, total income. The ranking of the top 10 companies’ changes drastically when they ranked based on total share capital and net profit. The financial stability of the companies can be described as they contribute more in market capitalization but are lagging behind in the ranking based on net profits and total share capital.
VL  - 1
IS  - 1
ER  -

Copy | Download

Author Information

Harishankar Sahu

MBA Pharmaceutical Management, School of Pharmaceutical Management, The IIHMR University, Jaipur, India
Naresh Mali

MBA Pharmaceutical Management, School of Pharmaceutical Management, The IIHMR University, Jaipur, India
Vrinda Mathur

MBA Pharmaceutical Management, School of Pharmaceutical Management, The IIHMR University, Jaipur, India

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Harishankar Sahu, Naresh Mali, Vrinda Mathur. (2016). Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016. International Journal of Accounting, Finance and Risk Management, 1(1), 39-45. https://doi.org/10.11648/j.ijafrm.20160101.16

Copy | Download

ACS Style

Harishankar Sahu; Naresh Mali; Vrinda Mathur. Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016. Int. J. Account. Finance Risk Manag. 2016, 1(1), 39-45. doi: 10.11648/j.ijafrm.20160101.16

Copy | Download

AMA Style

Harishankar Sahu, Naresh Mali, Vrinda Mathur. Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016. Int J Account Finance Risk Manag. 2016;1(1):39-45. doi: 10.11648/j.ijafrm.20160101.16

Copy | Download

@article{10.11648/j.ijafrm.20160101.16,
  author = {Harishankar Sahu and Naresh Mali and Vrinda Mathur},
  title = {Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016},
  journal = {International Journal of Accounting, Finance and Risk Management},
  volume = {1},
  number = {1},
  pages = {39-45},
  doi = {10.11648/j.ijafrm.20160101.16},
  url = {https://doi.org/10.11648/j.ijafrm.20160101.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijafrm.20160101.16},
  abstract = {The Indian Pharma industry is on a robust growth path and is likely to be in the top 10 global markets in value term by 2020. Indian pharmaceutical sector accounts for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and it is expecting to expand at a Compound Annual Growth Rate of 15.92 per cent to US$ 55 billion by 2020. By 2016-17, India is expecting to be the third-largest global generic Active Pharmaceutical Ingredient merchant market. This study seeks to describe the status of Indian pharmaceutical companies, their position, ranking, financial status and forecasting of future opportunities based on the financial predictors i.e. Net sales, total share capital net profit, total assets, total income. The ranking of the top 10 companies’ changes drastically when they ranked based on total share capital and net profit. The financial stability of the companies can be described as they contribute more in market capitalization but are lagging behind in the ranking based on net profits and total share capital.},
 year = {2016}
}

Copy | Download

TY  - JOUR
T1  - Financial Predictors Influencing the Ranking of Indian Pharmaceutical Companies 2016
AU  - Harishankar Sahu
AU  - Naresh Mali
AU  - Vrinda Mathur
Y1  - 2016/12/20
PY  - 2016
N1  - https://doi.org/10.11648/j.ijafrm.20160101.16
DO  - 10.11648/j.ijafrm.20160101.16
T2  - International Journal of Accounting, Finance and Risk Management
JF  - International Journal of Accounting, Finance and Risk Management
JO  - International Journal of Accounting, Finance and Risk Management
SP  - 39
EP  - 45
PB  - Science Publishing Group
SN  - 2578-9376
UR  - https://doi.org/10.11648/j.ijafrm.20160101.16
AB  - The Indian Pharma industry is on a robust growth path and is likely to be in the top 10 global markets in value term by 2020. Indian pharmaceutical sector accounts for about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and it is expecting to expand at a Compound Annual Growth Rate of 15.92 per cent to US$ 55 billion by 2020. By 2016-17, India is expecting to be the third-largest global generic Active Pharmaceutical Ingredient merchant market. This study seeks to describe the status of Indian pharmaceutical companies, their position, ranking, financial status and forecasting of future opportunities based on the financial predictors i.e. Net sales, total share capital net profit, total assets, total income. The ranking of the top 10 companies’ changes drastically when they ranked based on total share capital and net profit. The financial stability of the companies can be described as they contribute more in market capitalization but are lagging behind in the ranking based on net profits and total share capital.
VL  - 1
IS  - 1
ER  -

Copy | Download